Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 24Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Pancreatic Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

Nivolumab 2sotrovimab 1gusacitinib 1ciclesonide 1cabozantinib 1anifrolumab 1Standard of Care 1Specimen Handling 1Procalcitonin 1Practice Guidelines as Topic 1Platinum Compounds 1Niclosamide 1Methods 1Ipilimumab 1Interviews as Topic 1Immune Checkpoint Inhibitors 1High-Intensity Interval Training 1Exercise 1Educational Status 1Early Intervention, Educational 1Cholecalciferol 1CTLA-4 Antigen 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lupus Erythematosus, Systemic × Methods × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡